Difference between revisions of "About-cancer/treatment/drugs/thyroid"
Jump to navigation
Jump to search
(Created page with "== Drugs Approved for Thyroid Cancer == This page lists cancer drugs approved by the Food and Drug Administration (FDA) for thyroid cancer. The list includes generic names an...") |
(Marked this version for translation) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
| − | == Drugs Approved for Thyroid Cancer == | + | <languages/> |
| + | <translate> | ||
| + | == Drugs Approved for Thyroid Cancer == <!--T:1--> | ||
| + | <!--T:2--> | ||
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for thyroid cancer. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in thyroid cancer that are not listed here. | This page lists cancer drugs approved by the Food and Drug Administration (FDA) for thyroid cancer. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in thyroid cancer that are not listed here. | ||
| + | <!--T:3--> | ||
'''Drugs Approved for Thyroid Cancer''' | '''Drugs Approved for Thyroid Cancer''' | ||
| + | <!--T:4--> | ||
Cabozantinib-S-Malate | Cabozantinib-S-Malate | ||
| + | <!--T:5--> | ||
Caprelsa (Vandetanib) | Caprelsa (Vandetanib) | ||
| + | <!--T:6--> | ||
Cometriq (Cabozantinib-S-Malate) | Cometriq (Cabozantinib-S-Malate) | ||
| + | <!--T:7--> | ||
Dabrafenib Mesylate | Dabrafenib Mesylate | ||
| + | <!--T:8--> | ||
Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | ||
| + | <!--T:9--> | ||
Lenvatinib Mesylate | Lenvatinib Mesylate | ||
| + | <!--T:10--> | ||
Lenvima (Lenvatinib Mesylate) | Lenvima (Lenvatinib Mesylate) | ||
| + | <!--T:11--> | ||
Mekinist (Trametinib) | Mekinist (Trametinib) | ||
| + | <!--T:12--> | ||
Nexavar (Sorafenib Tosylate) | Nexavar (Sorafenib Tosylate) | ||
| + | <!--T:13--> | ||
Sorafenib Tosylate | Sorafenib Tosylate | ||
| + | <!--T:14--> | ||
Tafinlar (Dabrafenib Mesylate) | Tafinlar (Dabrafenib Mesylate) | ||
| + | <!--T:15--> | ||
Trametinib | Trametinib | ||
| + | <!--T:16--> | ||
Vandetanib | Vandetanib | ||
| + | </translate> | ||
Latest revision as of 21:41, 29 October 2019
Drugs Approved for Thyroid Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for thyroid cancer. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in thyroid cancer that are not listed here.
Drugs Approved for Thyroid Cancer
Cabozantinib-S-Malate
Caprelsa (Vandetanib)
Cometriq (Cabozantinib-S-Malate)
Dabrafenib Mesylate
Doxorubicin Hydrochloride
Lenvatinib Mesylate
Lenvima (Lenvatinib Mesylate)
Mekinist (Trametinib)
Nexavar (Sorafenib Tosylate)
Sorafenib Tosylate
Tafinlar (Dabrafenib Mesylate)
Trametinib
Vandetanib
